Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
13.76
+0.03 (0.18%)
Aug 14, 2025, 11:48 AM - Market open
Edgewise Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 43.4 | 41.67 | 86.1 | 21.99 | 15.57 | 104.92 | Upgrade
|
| Short-Term Investments | 550.59 | 428.5 | 232.3 | 329.95 | 265.22 | 24.18 | Upgrade
|
| Cash & Short-Term Investments | 593.99 | 470.17 | 318.39 | 351.95 | 280.79 | 129.09 | Upgrade
|
| Cash Growth | 16.07% | 47.67% | -9.53% | 25.34% | 117.51% | 445.78% | Upgrade
|
| Prepaid Expenses | 9.26 | 5.31 | 8.6 | 5.05 | 2.98 | 0.55 | Upgrade
|
| Total Current Assets | 603.26 | 475.48 | 327 | 357 | 283.77 | 129.65 | Upgrade
|
| Property, Plant & Equipment | 10.08 | 11.07 | 12.69 | 9.85 | 0.91 | 0.52 | Upgrade
|
| Long-Term Deferred Charges | - | 0.26 | 0.3 | 0.25 | - | 0.7 | Upgrade
|
| Other Long-Term Assets | - | - | 0.05 | - | 0.55 | 0.28 | Upgrade
|
| Total Assets | 613.33 | 486.82 | 340.04 | 367.1 | 285.23 | 131.14 | Upgrade
|
| Accounts Payable | 8.32 | 5.58 | 4.03 | 6.11 | 3.84 | 1.58 | Upgrade
|
| Accrued Expenses | 11.57 | 17.29 | 11.77 | 9.87 | 6.68 | 2.31 | Upgrade
|
| Current Portion of Leases | 1 | 1 | 0.98 | 0.61 | - | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | - | 0.45 | Upgrade
|
| Total Current Liabilities | 20.9 | 23.86 | 16.77 | 16.59 | 10.52 | 4.34 | Upgrade
|
| Long-Term Leases | 3.37 | 3.74 | 4.43 | 3.8 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.33 | - | Upgrade
|
| Total Liabilities | 24.26 | 27.6 | 21.21 | 20.39 | 10.85 | 4.34 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - | Upgrade
|
| Additional Paid-In Capital | 1,044 | 837.36 | 563.49 | 492.67 | 351.85 | 0.73 | Upgrade
|
| Retained Earnings | -455.49 | -378.58 | -244.76 | -144.6 | -76.96 | -34.15 | Upgrade
|
| Comprehensive Income & Other | 0.2 | 0.42 | 0.1 | -1.36 | -0.51 | - | Upgrade
|
| Total Common Equity | 589.07 | 459.22 | 318.83 | 346.72 | 274.38 | -33.42 | Upgrade
|
| Shareholders' Equity | 589.07 | 459.22 | 318.83 | 346.72 | 274.38 | 126.79 | Upgrade
|
| Total Liabilities & Equity | 613.33 | 486.82 | 340.04 | 367.1 | 285.23 | 131.14 | Upgrade
|
| Total Debt | 4.37 | 4.74 | 5.41 | 4.41 | - | - | Upgrade
|
| Net Cash (Debt) | 589.62 | 465.43 | 312.98 | 347.54 | 280.79 | 129.09 | Upgrade
|
| Net Cash Growth | 16.35% | 48.71% | -9.94% | 23.77% | 117.51% | 445.78% | Upgrade
|
| Net Cash Per Share | 6.07 | 5.04 | 4.91 | 6.48 | 7.48 | 174.69 | Upgrade
|
| Filing Date Shares Outstanding | 105.35 | 95.21 | 93.11 | 63.26 | 49.51 | 1.01 | Upgrade
|
| Total Common Shares Outstanding | 105.34 | 94.84 | 70.45 | 63.26 | 49.5 | 1.01 | Upgrade
|
| Working Capital | 582.36 | 451.62 | 310.23 | 340.41 | 273.25 | 125.3 | Upgrade
|
| Book Value Per Share | 5.59 | 4.84 | 4.53 | 5.48 | 5.54 | -33.11 | Upgrade
|
| Tangible Book Value | 589.07 | 459.22 | 318.83 | 346.72 | 274.38 | -33.42 | Upgrade
|
| Tangible Book Value Per Share | 5.59 | 4.84 | 4.53 | 5.48 | 5.54 | -33.11 | Upgrade
|
| Machinery | 4.67 | 4.54 | 4.25 | 2.26 | 1.61 | - | Upgrade
|
| Construction In Progress | - | - | 0.08 | 7.34 | - | - | Upgrade
|
| Leasehold Improvements | 9.65 | 9.65 | 8.73 | - | - | - | Upgrade
|
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.